Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LFMD
#3147
LifeMD, Inc. - Common Stock
4.2
8
USD
-6.75%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-6.75%
Monthly Change
-3.39%
6 month change
+14.75%
Year Change
-62.94%
Previous Close
4.5
9
Open
4.2
8
Low
4.2
8
High
4.2
8
Volume
72
Markets
US Stock Market
Healthcare
LFMD
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
2025
Total assets
13.05 M
49.92 M
25.67 M
58.48 M
72.46 M
70.41 M
Total liabilities
13.88 M
24.1 M
32.97 M
52.91 M
76.51 M
47.25 M
Total equity
-4.48 M
21.71 M
-11.87 M
5.57 M
-4.05 M
23.16 M
Total liabilities & shareholders' equities
13.05 M
49.92 M
25.67 M
58.48 M
72.46 M
70.41 M
Total debt
—
—
—
18.26 M
18.33 M
0
Net debt
—
—
—
-14.89 M
-16.68 M
-36.79 M
LifeMD, Inc. - Common Stock
LifeMD, Inc. is a publicly traded American telehealth company. It gives subscribers access to doctors and nurse practitioners for virtual medical consultations and treatments with prescription medications.
News
Hims & Hers Expands Integrated Health Access via Platform Expansion
Is CAH Becoming the Backbone of US Healthcare Infrastructure?
LifeMD, Inc. (LFMD) Q1 2026 Earnings Call Transcript
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
LifeMD (LFMD) Soars 23.7%: Is Further Upside Left in the Stock?
Hims & Hers Powers Patient-Provider Connectivity via Digital Platforms
Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?
Hims & Hers Expands Integrated Digital Healthcare Ecosystem
LifeMD names Atul Kavthekar as CFO, announces leadership changes
Mizuho upgrades LifeMD stock rating on weight-loss outlook
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock?